The Maryland Department of Health held open public comment for proposed regulation COMAR 10.34.43, "Prescription Labeling for Blind, Visually Impaired, and Print Disabled Individuals." The regulation implements 2023’s Senate Bill 940, which requires the state board of pharmacy to adopt regulations to ensure patients who are blind, visually impaired, or otherwise print disabled have access to prescription labels, tags, and medical guides.
NCPA sent comments concerning the increased financial burden on community pharmacies to meet the labeling requirements. The board of pharmacy has estimated that the additional cost of leasing labeling equipment could be at least $2,600 per year, and that maintenance costs will increase over time.
NCPA
